查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790351

美國微陣列市場規模、佔有率和趨勢分析報告：按產品/服務、類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Microarray Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Software & Services), By Type (DNA Microarray, Protein Microarray), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

美國微陣列市場規模與趨勢

預計 2024 年美國微陣列市場價值將達到 26.5 億美元，預計 2025 年至 2033 年的複合年成長率為 5.7%。

個人化醫療（尤其是精準腫瘤學和藥物基因組學）需求的蓬勃發展推動了市場的發展。隨著美國國立衛生研究院 (NIH)、大學和生物技術公司不斷增加的投資，微陣列在識別生物標記、分析基因表現、客製化治療方法以及最終改善患者預後方面發揮著重要作用。此外，癌症和慢性病的日益普及也促使人們越來越依賴微陣列等先進的基因組工具進行早期檢測和藥物研發。

癌症研究的最新進展極大地促進了微陣列儀器和試劑的應用，以提高診斷準確性和分子分析能力。微陣列平台擴大用於基因表現分析，使研究人員能夠識別癌症特異性生物標記、預測預後並指導標靶治療。在美國，賽默飛世爾科技、安捷倫科技和 Illumina 等公司推出了針對高通量檢測和低輸入 RNA/DNA 樣本而最佳化的尖端試劑組，這對於腫瘤切片檢查分析至關重要。例如，賽默飛世爾的 GeneChip 研究試劑支持癌症研究中的全轉錄組分析，而安捷倫的 SureTag DNA 標記試劑套件可為癌細胞遺傳學中的比較基因組雜合反應(CGH) 提供可靠的雜合反應。 Illumina 的 Infinium 檢測試劑套件與 iScan 系統廣泛相容，可同時分析甲基化和 SNP 圖譜，支持表觀遺傳癌症研究。

美國微陣列技術的投資和創新不斷擴大，預計將加速市場成長，尤其是在皮內貼劑等下一代應用領域。 2023年3月，總部位於麻薩諸塞州的生技公司Vaxes Technologies獲得900萬美元額外融資，推進其MIMIX緩釋性皮內微陣列貼片平台。此創新平台旨在透過實現自我給藥和經皮貼劑緩釋性給藥，徹底改變疫苗和治療的給藥方式。資金籌措由RA Capital Management和Enjin（麻省理工學院的創投基金）等知名美國投資者主導，將支持正在進行的流感疫苗和新冠疫苗臨床試驗，並拓展該平台在腫瘤學、自體免疫疾病和代謝性疾病領域的應用。

除了醫療保健領域，微陣列技術在美國農業和環境科學領域也蓬勃發展。在精密農業，微陣列技術被用於對植物性因組進行定序，並識別能夠增強抗病蟲害和氣候壓力的性狀，從而應對美國的糧食安全挑戰。此外，環境機構和學術機構擴大使用基於微陣列的毒理學基因組學檢測來評估污染物對當地生態系統基因表現的影響。微陣列儀器和試劑的應用範圍廣泛，涵蓋從臨床研究到永續性的各個領域，它們在推動美國各個領域的創新方面發揮著越來越重要的作用。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國微陣列市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國微陣列市場分析工具
    • 產業分析波特五力分析
    • PESTEL分析

第4章美國微陣列市場：產品與服務、估價與趨勢分析

  • 2024年和2033年的產品和服務市場佔有率
  • 細分儀表板
  • 美國微陣列市場：產品與服務展望
  • 2021年至2033年市場規模、預測與趨勢分析
    • 耗材
    • 裝置
    • 軟體和服務

第5章美國微陣列市場類型、估值與趨勢分析

  • 2024年和2033年的類型市場佔有率
  • 細分儀表板
  • 美國微陣列市場展望（按類型）
  • 2021年至2033年市場規模、預測與趨勢分析
    • DNA微陣列
    • 蛋白質微陣列
    • 其他

第6章：美國微陣列市場的應用、預測與趨勢分析

  • 2024 年和 2033 年應用市場佔有率
  • 細分儀表板
  • 美國微陣列市場：應用前景
  • 2021年至2033年市場規模、預測與趨勢分析
    • 研究用途
    • 藥物研發
    • 疾病診斷
    • 其他

第7章美國微陣列市場：依最終用途的估計和趨勢分析

  • 2024年和2033年的最終用途市場佔有率
  • 細分儀表板
  • 美國微陣列市場：依最終用途分類的展望
  • 2021年至2033年市場規模、預測與趨勢分析
    • 研究和學術機構
    • 製藥和生物技術公司
    • 診斷實驗室
    • 其他

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Thermo Fisher Scientific Inc（Applied Biosystems）
    • Agilent Technologies, Inc
    • Illumina, Inc
    • PerkinElmer
    • Merck KGaA
    • Schott（Applied Microarrays）
    • Danaher Corporation
    • Arrayit Corporation
    • Bio-Rad Laboratories, Inc
    • Microarrays Inc
Product Code: GVR-4-68040-671-7

U.S. Microarray Market Size & Trends:

The U.S. microarray market size was estimated at USD 2.65 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2033. The market is driven by the surging demand for personalized medicine, especially in precision oncology and pharmacogenomics. With rising investments from the NIH, universities, and biotech firms, microarrays are invaluable for identifying biomarkers, profiling gene expression, and tailoring therapeutic regimens-ultimately improving patient outcomes. In addition, the escalating prevalence of cancer and chronic diseases further enhances reliance on high-throughput genomic tools like microarrays for early detection and drug discovery.

Recent advancements in cancer research have significantly leveraged microarray instruments and reagents to enhance diagnostic accuracy and molecular profiling. Microarray platforms are increasingly used for gene expression profiling, allowing researchers to identify cancer-specific biomarkers, predict prognosis, and guide targeted therapies. In the U.S., companies such as Thermo Fisher Scientific, Agilent Technologies, and Illumina have introduced updated reagent kits optimized for high-throughput assays and low input RNA/DNA samples-critical for analyzing tumor biopsies. For instance, Thermo Fisher's GeneChip reagents support whole-transcriptome analysis in oncology research, while Agilent's SureTag DNA labeling kits enable robust hybridization for comparative genomic hybridization (CGH) in cancer cytogenetics. Illumina's Infinium assay kits, widely compatible with the iScan system, allow for simultaneous interrogation of methylation and SNP profiles, aiding in epigenetic cancer studies.

Growing investment and innovation in U.S.-based microarray technologies are poised to accelerate market growth, particularly in next-generation applications such as intradermal patch delivery. In March 2023, Vaxess Technologies, a Massachusetts-based biotech firm, secured an additional USD 9 million in funding to advance its MIMIX sustained-release intradermal microarray patch platform. This novel platform aims to revolutionize vaccine and therapeutic delivery by enabling self-administered, extended-release dosing through a skin patch. The funding, led by prominent U.S. investors such as RA Capital Management and The Engine (MIT's venture fund), will support ongoing clinical trials for influenza and COVID-19 vaccines and broaden the platform's applications into oncology, autoimmune diseases, and metabolic disorders.

Beyond healthcare, microarray technologies are gaining momentum in U.S. agriculture and environmental science. In precision farming, microarrays are used to decode plant genomes and identify traits that enhance resistance to pests and climate stressors, which are addressing U.S. food security challenges. Additionally, environmental agencies and academic institutions are increasingly using microarray-based toxicogenomic assays to evaluate the impact of pollutants on gene expression in local ecosystems. This multifaceted applicability-from clinical research to sustainability continues to expand the role of microarray instruments and reagents in driving innovation across sectors in the United States.

U.S. Microarray Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. microarray market report based on products and services, type, application, and end use.

  • Product and Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Software and Services
  • Instruments
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Microarrays
  • Protein Microarrays
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product and Services
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and Services Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Microarray Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for personalized medicine and genomic research
      • 3.2.1.2. Technological advancements in microarray platforms
      • 3.2.1.3. Expanding applications in diagnostics and infectious disease testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of microarray instruments and consumables
  • 3.3. U.S. Microarray Market Analysis Tools
    • 3.3.1. Industry Analysis Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Microarray Market: Product and Services Estimates & Trend Analysis

  • 4.1. Product and Services Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. U.S. Microarray Market by Product and Services Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Consumables
      • 4.4.1.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Software and Services
      • 4.4.3.1. Software and services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Microarray Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. U.S. Microarray Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. DNA Microarray
      • 5.4.1.1. DNA Microarray market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Protein Microarray
      • 5.4.2.1. Protein microarray market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Microarray Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. U.S. Microarray Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Research applications
      • 6.4.1.1. Research application market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Drug discovery
      • 6.4.2.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Disease diagnostics
      • 6.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others application market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Microarray Market: End use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. U.S. Microarray Market by End use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 7.4.1. Research and Academic Institutes
      • 7.4.1.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Pharmaceutical and Biotechnology Companies
      • 7.4.2.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Diagnostic Laboratories
      • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc (Applied Biosystems)
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Services benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Agilent Technologies, Inc
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Services benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Illumina, Inc
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Services benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. PerkinElmer
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Services benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Services benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Schott (Applied Microarrays)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Services benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Danaher Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Services benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Arrayit Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Services benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Rad Laboratories, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Services benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Microarrays Inc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Services benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 U.S. microarray market, by product and services, 2021 - 2033 (USD Million)
  • Table 4 U.S. microarray market, by type, 2021 - 2033 (USD Million)
  • Table 5 U.S. microarray market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. microarray market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Market outlook
  • Fig. 9 Segment snapshot-1
  • Fig. 10 Segment snapshot-2
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market trends & outlook
  • Fig. 13 Porter's five force analysis
  • Fig. 14 PESTEL analysis
  • Fig. 15 U.S. microarray market: Product and Services outlook key takeaways
  • Fig. 16 U.S. microarray market: Product and Services movement analysis
  • Fig. 17 U.S. Microarray: Product and Services movement analysis
  • Fig. 18 U.S. Microarray: Product and Services outlook and key takeaways
  • Fig. 19 Consumables market estimates and forecast, 2021 - 2033
  • Fig. 20 Instruments market estimates and forecast, 2021 - 2033
  • Fig. 21 Software and services market estimates and forecast, 2021 - 2033
  • Fig. 22 U.S. Microarray: Type movement analysis
  • Fig. 23 U.S. Microarray: Type outlook and key takeaways
  • Fig. 24 DNA microarray market estimates and forecasts, 2021 - 2033
  • Fig. 25 Protein microarray market estimates and forecasts, 2021 - 2033
  • Fig. 26 Others market estimates and forecasts, 2021 - 2033
  • Fig. 27 U.S. Microarray: Application movement analysis
  • Fig. 28 U.S. Microarray: application outlook and key takeaways
  • Fig. 29 Research applications market estimates and forecasts, 2021 - 2033
  • Fig. 30 Drug discovery market estimates and forecasts, 2021 - 2033
  • Fig. 31 Disease diagnostics market estimates and forecasts, 2021 - 2033
  • Fig. 32 Others applications market estimates and forecasts, 2021 - 2033
  • Fig. 33 U.S. Microarray: End Use movement analysis
  • Fig. 34 U.S. Microarray: End Use outlook and key takeaways
  • Fig. 35 Research and academic institutes market estimates and forecasts, 2021 - 2033
  • Fig. 36 Pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033
  • Fig. 37 Diagnostic laboratories market estimates and forecasts, 2021 - 2033
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033